The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease.
作者信息
Wang Ming, Wang Bixia, Xu Lan-Ping, Wang Yu, Zhang Xiao-Hui, Cheng Yi-Fei, Sun Yu-Qian, Zhang Yuan-Yuan, Liu Yan-Rong, Chang Ying-Jun, Liu Kai-Yan, Huang Xiao-Jun
机构信息
Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
出版信息
Bone Marrow Transplant. 2023 Feb;58(2):215-218. doi: 10.1038/s41409-022-01872-7. Epub 2022 Nov 14.
PMID:36376473
Abstract
摘要
Zotero 插件